The Netherlands is a leader in the life sciences and biotech industry, ranked as No.4 worldwide for medical technology patent applications and No. 9 worldwide for biotechnology patent applications.
More than 2,500 life sciences, medical technology companies and research organisations call the country home, and the region has attracted major multinational companies, including Johnson & Johnson, GlaxoSmithKline, Amgen and Medtronic, as a hub for manufacturing, R&D and logistics.
With the majority of innovative life sciences companies clustered within a 120 mile radius, collaboration is a key focus.
In 2016, the two largest public private institutes in the life sciences and health sector, the Centre for Translational Molecular Medicine and the Top Institute Pharma, came together to form Lygature. This independent third party was created to help preserve Dutch R&D expertise and support new initiatives, driving the development of innovative medical solutions.
R&D is also a core focus, receiving an estimated 2 Billion Euros in investment each year.
This has undoubtedly contributed to the global success of Dutch life sciences, such as the Leiden Bio Science Park, which has consistently ranked in the top five most successful science parks in Europe. The Park houses 93 dedicated medical life sciences companies and institutions, internationally acclaimed research institutes and the largest number of bioscience start-ups in Holland.
With the help of Biotechgate, a global Life Sciences database covering Biotechnology, Pharmaceuticals and the Medical Devices industry, we have put together an overview analysis of the Dutch Life Sciences industry in 2017.
This analysis includes the key activities of life sciences companies, the number of products in development and a 5 year financing report…